“…The current study [3] demonstrated the effectiveness of tyrosine kinase inhibitors in treating patients who have advanced sarcomas with tyrosine kinase fusion genes. Nonetheless, we must exercise caution when thinking about the potential clinical benefits of this The opinions expressed are those of the writer, and do not reflect the opinion or policy of CORR ® or The Association of Bone and Joint Surgeons ® .…”